Xpect Vision Technology

About Xpect Vision Technology

Xpect Vision Technology, established in January 2015, operates as a manufacturer of advanced medical imaging systems, headquartered in Shenzhen with additional research and development branches in Beijing and Shanghai. The company has secured significant financial backing, raising a total of $27.2 million over four funding rounds, including a Series C in December 2021, with investors such as IDG Capital, CICC, and Northern Light Venture Capital.

The firm's core business revolves around the development and mass production of photon-counting X-ray detectors and the complete imaging systems that use them. This technology, which represents a next-generation approach to X-ray imaging, is applied across medical, industrial, and scientific research sectors. The business model is centered on manufacturing and selling these high-performance imaging systems to a global client base, with primary markets in North and South America, Europe, Asia, and Africa. Its products are distributed through partners and are used by dental professionals and medical practitioners worldwide.

Xpect Vision's flagship product is the world's first photon-counting intraoral sensor for dental imaging. This technology allows for direct X-ray imaging without the need for conversion to visible light, a process that avoids the light scattering seen in conventional systems. Key benefits include higher image quality with greater detail and gray-level depth, reduced radiation exposure for patients, and rapid image acquisition within three seconds. The sensor is also noted for its durability and waterproof design. Recently, the platform has been upgraded to include AI-powered features for real-time diagnostic assistance, helping to identify caries, anomalies, and bone loss more confidently. Beyond dental applications, the company's portfolio includes digital mammography systems and X-ray stress analyzers for industrial and scientific use.